tiprankstipranks
Advertisement
Advertisement

CLDX Stock Latest News

Canaccord sees potential Apogee buyout as ‘huge win’ for sector
The FlyCanaccord sees potential Apogee buyout as ‘huge win’ for sector
3d ago
ABBV
APGE
Celldex presents long-term results from Phase 2 study of barzolvolimab
PremiumThe Fly
Celldex presents long-term results from Phase 2 study of barzolvolimab
10d ago
CLDX
Celldex presents first-in-human results for CDX-622
PremiumThe Fly
Celldex presents first-in-human results for CDX-622
10d ago
CLDX
Celldex price target raised to $45 from $38 at UBS
PremiumThe Fly
Celldex price target raised to $45 from $38 at UBS
15d ago
CLDX
Celldex price target raised to $54 from $38 at Wells Fargo
PremiumThe Fly
Celldex price target raised to $54 from $38 at Wells Fargo
1M ago
CLDX
Celldex price target raised to $38 from $34 at Goldman Sachs
PremiumThe FlyCelldex price target raised to $38 from $34 at Goldman Sachs
2M ago
CLDX
Celldex price target raised to $48 from $45 at Barclays
Premium
The Fly
Celldex price target raised to $48 from $45 at Barclays
2M ago
CLDX
Celldex reports Q1 EPS ($1.18), consensus ($1.13)
Premium
The Fly
Celldex reports Q1 EPS ($1.18), consensus ($1.13)
2M ago
CLDX
Celldex sees funds sufficient to fund current planned operations through 2028
PremiumThe Fly
Celldex sees funds sufficient to fund current planned operations through 2028
2M ago
CLDX
CLDX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CLDX Earnings this Week: How Will it Perform?
2M ago
CLDX
Morning News Wrap-Up, 4/20/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up, 4/20/26: Today’s Biggest Stock Market Stories!
2M ago
AMD
DIA
A Top Wall Street Analyst ‘Can’t Ignore’ Celldex Stock (CLDX)
PremiumMarket News
A Top Wall Street Analyst ‘Can’t Ignore’ Celldex Stock (CLDX)
2M ago
CLDX
Celldex upgraded to Overweight from Underweight at Barclays
PremiumThe FlyCelldex upgraded to Overweight from Underweight at Barclays
2M ago
CLDX
Celldex Announces Major Underwritten Public Equity Offering
Premium
Company Announcements
Celldex Announces Major Underwritten Public Equity Offering
3M ago
8K
CLDX
Celldex 10.345M share Spot Secondary priced at $29.00
Premium
The Fly
Celldex 10.345M share Spot Secondary priced at $29.00
3M ago
CLDX
Closing Bell Movers: Globalstar spikes on acquisition report
PremiumThe Fly
Closing Bell Movers: Globalstar spikes on acquisition report
3M ago
FC
AMZN
Celldex announces common stock offering, no amount given
PremiumThe Fly
Celldex announces common stock offering, no amount given
3M ago
CLDX
Celldex data shows improvements across six DLQI Domains in barzolvolimab trials
PremiumThe Fly
Celldex data shows improvements across six DLQI Domains in barzolvolimab trials
3M ago
CLDX
Celldex upgraded to Outperform from Peer Perform at Wolfe Research
PremiumThe Fly
Celldex upgraded to Outperform from Peer Perform at Wolfe Research
3M ago
CLDX
Celldex price target raised to $34 from $30 at Goldman Sachs
PremiumThe FlyCelldex price target raised to $34 from $30 at Goldman Sachs
4M ago
CLDX
Celldex: Barzolvolimab’s Durable Efficacy in Chronic Urticaria Underpins Buy Rating Ahead of Key Late-Stage Catalysts
Premium
Ratings
Celldex: Barzolvolimab’s Durable Efficacy in Chronic Urticaria Underpins Buy Rating Ahead of Key Late-Stage Catalysts
4M ago
CLDX
Celldex presents new data from Phase 2 ColdU, SD Open Label Extension
Premium
The Fly
Celldex presents new data from Phase 2 ColdU, SD Open Label Extension
4M ago
CLDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >